ArticleCureus2024
Pseudoachalasia Secondary to Metastatic Osteosarcoma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudoachalasia is a disorder in which symptoms, radiologic, endoscopic, and manometric results resemble idiopathic achalasia. Although these diagnoses may appear similar, their underlying causes and therapy differ significantly. Pseudoachalasia is frequently associated with malignancy, particularly primary adenocarcinoma of the esophagus or cardia. We present a 75-year-old female patient with metastatic osteosarcoma who presented with symptoms of dysphagia and typical esophageal manometry findings of achalasia. Esophagoscopy showed resistance while crossing the gastroesophageal junction. Abdominal computed tomography showed a mediastinal mass. An endoscopic ultrasound was performed, and a fine needle biopsy was taken from mediastinal deposits. Histopathology, which showed signet cell tumor cells. As the cancer was inoperable, chemotherapy was started and her symptoms have decreased from before. Typical esophageal dysmotility can be seen in pseudoachalasia, a secondary type of achalasia caused mostly by cancer or benign tumors, surgical complications, or paraneoplastic disorders. Hence we can conclude diagnosing pseudoachalasia earlier can improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.